| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:LRN) with a Buy and raises the price target from $165 to $175.
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and maintains $185 price target.
Barrington Research analyst Alexander Paris maintains Stride (NYSE:LRN) with a Outperform and raises the price target from $...
Morgan Stanley analyst Greg Parrish maintains Stride (NYSE:LRN) with a Equal-Weight and raises the price target from $148 to...